Eterna Therapeutics Statistics
Total Valuation
ERNA has a market cap or net worth of $27.85 million. The enterprise value is $65.02 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ERNA has 51.37 million shares outstanding. The number of shares has increased by 11.09% in one year.
Current Share Class | 51.37M |
Shares Outstanding | 51.37M |
Shares Change (YoY) | +11.09% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 48.62% |
Owned by Institutions (%) | 10.02% |
Float | 21.26M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.56 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 108.72 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48
Current Ratio | 0.48 |
Quick Ratio | 0.45 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.35 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -42.35% |
Return on Capital (ROIC) | -71.61% |
Revenue Per Employee | $74,750 |
Profits Per Employee | -$5.62M |
Employee Count | 8 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ERNA has paid $15,000 in taxes.
Income Tax | 15,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.60% in the last 52 weeks. The beta is 7.76, so ERNA's price volatility has been higher than the market average.
Beta (5Y) | 7.76 |
52-Week Price Change | -45.60% |
50-Day Moving Average | 1.08 |
200-Day Moving Average | 1.71 |
Relative Strength Index (RSI) | 24.77 |
Average Volume (20 Days) | 130,403 |
Short Selling Information
The latest short interest is 44,458, so 0.09% of the outstanding shares have been sold short.
Short Interest | 44,458 |
Short Previous Month | 61,003 |
Short % of Shares Out | 0.09% |
Short % of Float | 0.21% |
Short Ratio (days to cover) | 1.07 |
Income Statement
In the last 12 months, ERNA had revenue of $598,000 and -$44.95 million in losses. Loss per share was -$8.31.
Revenue | 598,000 |
Gross Profit | 436,000 |
Operating Income | -20.32M |
Pretax Income | -22.90M |
Net Income | -44.95M |
EBITDA | -20.18M |
EBIT | -20.32M |
Loss Per Share | -$8.31 |
Full Income Statement Balance Sheet
The company has $4.26 million in cash and $37.70 million in debt, giving a net cash position of -$33.43 million or -$0.65 per share.
Cash & Cash Equivalents | 4.26M |
Total Debt | 37.70M |
Net Cash | -33.43M |
Net Cash Per Share | -$0.65 |
Equity (Book Value) | -45.39M |
Book Value Per Share | -8.39 |
Working Capital | -5.22M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$16.95 million and capital expenditures -$388,000, giving a free cash flow of -$17.34 million.
Operating Cash Flow | -16.95M |
Capital Expenditures | -388,000 |
Free Cash Flow | -17.34M |
FCF Per Share | -$0.34 |
Full Cash Flow Statement Margins
Gross Margin | 72.91% |
Operating Margin | -3,397.66% |
Pretax Margin | -7,511.37% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -15,845.22% |